New 52 Week High Today

AstraZeneca PLC AZN:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/10/24 EDT
77.21quote price arrow up+0.03 (+0.04%)
Volume
48,619
Close
77.18quote price arrow down-0.43 (-0.55%)
Volume
3,541,810
52 week range
60.47 - 77.93
Loading...
  • Open77.77
  • Day High77.93
  • Day Low77.14
  • Prev Close77.61
  • 52 Week High77.93
  • 52 Week High Date05/10/24
  • 52 Week Low60.47
  • 52 Week Low Date02/12/24

Key Stats

  • Market Cap239.294B
  • Shares Out3.10B
  • 10 Day Average Volume6.79M
  • Dividend1.45
  • Dividend Yield1.88%
  • Beta0.49
  • YTD % Change14.6

KEY STATS

  • Open77.77
  • Day High77.93
  • Day Low77.14
  • Prev Close77.61
  • 52 Week High77.93
  • 52 Week High Date05/10/24
  • 52 Week Low60.47
  • 52 Week Low Date02/12/24
  • Market Cap239.294B
  • Shares Out3.10B
  • 10 Day Average Volume6.79M
  • Dividend1.45
  • Dividend Yield1.88%
  • Beta0.49
  • YTD % Change14.6

RATIOS/PROFITABILITY

  • EPS (TTM)2.03
  • P/E (TTM)38.06
  • Fwd P/E (NTM)14.51
  • EBITDA (TTM)13.775B
  • ROE (TTM)17.29%
  • Revenue (TTM)47.611B
  • Gross Margin (TTM)82.17%
  • Net Margin (TTM)13.31%
  • Debt To Equity (MRQ)92.27%

EVENTS

  • Earnings Date07/25/2024(est)
  • Ex Div Date02/22/2024
  • Div Amount0.985
  • Split Date-
  • Split Factor-

Profile

MORE
AstraZeneca PLC is a science-led biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory and immunology. Its pipeline forms a portfolio of investigational therapies in various stages of clinical development and includes the Alexion Rare Disease portfolio comprising approximately 178 projects....
Michel Demare
Non-Executive Independent Chairman of the Board
Pascal Soriot
Chief Executive Officer, Executive Director
Aradhana Sarin M.D.
Chief Financial Officer, Executive Director
Ruud Dobber Ph.D.
Executive Vice President - BioPharmaceuticals Business Unit
Susan Galbraith
Executive Vice President - Oncology and Research and Development
Address
1 Francis Crick Avenue
Cambridge
CB2 0AA
United Kingdom

Top Peers

SYMBOLLASTCHG%CHG
NVS
Novartis AG
102.10+1.89+1.89%
ABBV
AbbVie Inc
160.75+0.35+0.22%
PFE
Pfizer Inc
28.01-0.17-0.60%
AMGN
Amgen Inc
310.15-2.71-0.87%
RHHBY
Roche Holding AG
30.95+0.05+0.16%